CJC-1295 with DAC vs Vesilute

Well Studied vs Moderate Research
synergistic Mechanism-based · 47% CJC-1295 with DAC and Vesilute work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.

Molecular Data

CJC-1295 with DAC Vesilute
Weight 3,647.28 Da 262 Da
Half-life 6-8 days Not established
Chain 30 amino acids 2 amino acids
Type GHRH analog with DAC Dipeptide bioregulator

Key Benefits

CJC-1295 with DAC
01 Convenient weekly dosing
02 Sustained GH/IGF-1 elevation
03 6-8 day half-life
04 Significant body composition changes
Vesilute
01 Supports bladder and urinary tract function
02 May improve prostate health in men
03 Regulates smooth muscle function
04 Enhances pelvic tissue blood flow
05 Supports cellular regeneration
06 Part of comprehensive Khavinson bioregulator protocols
07 Well-tolerated in research
08 Oral bioavailability as small dipeptide

Dosing Protocols

CJC-1295 with DAC
1-2mg weekly / Once or twice weekly (e.g., Monday/Thursday for split dosing)
Conservative Anti-Aging 1mg Once weekly
Standard Protocol 2mg Once weekly
Split Dosing 1mg Twice weekly (Mon/Thu)
Loading Protocol 2mg first week, then 1mg Weekly
Vesilute
10-20 mg per day / Daily for 10-20 consecutive days (Khavinson bioregulator cycle)
Standard protocol 10-20 mg Daily for 10-20 days
Maintenance 20 mg 2-3 cycles yearly

Side Effects

CJC-1295 with DAC
Water retention
Joint pain
Carpal tunnel symptoms
Vesilute
Generally well-tolerated
Injection site reactions (mild, if injectable)
Minimal reported side effects
Contraindications
Diabetes history
Cancer history
Predisposed sleep apnea
Known hypersensitivity to peptide components
Active urinary tract infection (treat first)
Pregnancy or breastfeeding
Prostate cancer (consult physician)

Research Evidence

CJC-1295 with DAC Vesilute
Status Well Studied Moderate Research
References 4 studies 3 studies
Latest 2025
FDA Approved No No

This comparison is for educational and research purposes only. Consult a healthcare professional before use.